✦ LIBER ✦

Treatment of the blastic phase of chronic myelogenous leukemia with mitoxantrone and high-dose cytosine arabinoside

✍ Scribed by Hagop M. Kantarjian; Ronald S. Walters; Michael J. Keating; Moshe Talpaz; Borje Andersson; Miloslav Beran; Kenneth B. McCredie; Emil J Freireich

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 511 KB
Volume: 62
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19880815)62:4<672::aid-cncr2820620404>3.0.co;2-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitoxantrone and high-dose cytosine arab

Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia

✍ Hagop M. Kantarjian; Ronald L. Walters; Michael J. Keating; Elihu H. Estey; SUSA 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB 👁 2 views

Twenty-five adult patients with refractory acute lymphocytic leukemia received salvage therapy with mitoxantrone 5 mg/m2 intravenously over 1 hour daily for 5 days and cytosine arabinoside 3 g/m2 intravenously over 2 hours every 12 hours for six doses. Overall, nine patients (36%) achieved complete

Autologous peripheral stem cell transpla

Autologous peripheral stem cell transplantation of the blastic phase of chronic myeloid leukemia following sequential high-dose cytosine arabinoside and melphalan

✍ Ursula A. Matulonis; James D. Griffin; Dr. George P. Canellos 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 2 views

High-dose cytosine arabinoside and idaru

High-dose cytosine arabinoside and idarubicin treatment of chronic myeloid leukemia in myeloid blast crisis

✍ Steven Barone; Maria R. Baer; Sheila N.J. Sait; David Lawrence; AnneMarie W. Blo 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB 👁 2 views

Treatment of acute nonlymphocytic leukem

Treatment of acute nonlymphocytic leukemia in the elderly with intermediate high-dose cytosine arabinoside

✍ Letendre, Louis ;Niedringhaus, Robert D. ;Therneau, Terry M. ;Gastineau, Dennis 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB 👁 1 views

Effective treatment of the elderly patients (265 years) with acute nonlymphocytic leukemia (ANLL) remains elusive and controversial. In the present study, single-agent Cytosine Arabinoside (AM-C) was administered at an intermediate dose level (500 mg/m2 intravenously [I.V.] I-hour infusion q12 hours

A Phase I–II trial of escalating doses o

A Phase I–II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia

✍ Charles A. Koller; Hagop M. Kantarjian; Eric J. Feldman; Susan O'Brien; Mary Bet 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

## BACKGROUND. Cytarabine is an essential drug for inducing remission of acute myelogenous leukemia, and it is also one the most effective drugs used as salvage therapy for patients with all types of relapsed acute leukemia. Nevertheless, there is considerable room for improvement in the treatment

High antileukemic activity of sequential

High antileukemic activity of sequential high dose cytosine arabinoside and mitoxantrone in patients with refractory acute leukemias : Results of a clinical Phase II study

✍ Wolfgang Kern; Eberhard Schleyer; Michael Unterhalt; Bernhard Wörmann; Thomas Bü 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 2 views

Department of Heremission whereas 5 patients (23%) succumbed to early death and 3 patients (14%) matology and Oncology, Go ¨ttingen, Germany. did not respond. Blood counts recovered at a median of 33.5 days after the start 2 Westfa ¨lische Wilhelms University, Department of treatment and complete r